| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |